CordenPharma at TIDES Europe 2026

Nov 3–5, 2026 Amsterdam, Netherlands ~900 attendees Website

CordenPharma takes part in 2 sessions at TIDES Europe 2026 in Amsterdam, and exhibits. Its program centres on peptide preclinical and clinical development. It covers phase-appropriate development and integrated drug product supply as ways to reach a Phase I start sooner.

OrganizationTIDES Europe 2026 Attendance
CDMO & CROSilver sponsor
Contract development and manufacturing organization for peptides, oligonucleotides, lipids and complex APIs, with integrated drug product supply.
Booth
Exhibiting (no floor booth listed)
Wed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm
Talk
Wed Nov 4
14:30–15:00
Accelerate Timeline to Start PhI: Phase Appropriate Development and Integrated Drug Product Supply
Running peptide drug substance and finished-product development side by side to reach safety testing and the first human trial sooner.
Talk
Thu Nov 5
13:55–14:00
Chairman’s Remarks: Peptide Preclinical and Clinical
Peptide Discovery to CMC

Explore the full TIDES Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Amsterdam. Leave your work email and we’ll be in touch.

Privacy

Download the full TIDES Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from CordenPharma

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Informa Connect or TIDES Europe. Submit a correction